abstract |
The present invention provides compounds of formula (I) useful for modulating the biological activity of the melanocortin-5 receptor (MC5R). The compounds of the invention can be used to treat diseases and / or conditions where down-regulation of MC5R is beneficial. Such diseases and / or symptoms include, but are not limited to, pressure ulcers, seborrhea, seborrheic dermatitis, cancer, and inflammatory diseases. [Selection figure] None |